Literature DB >> 25432179

Imaging of central neurocytomas.

Daniel Donoho1, Gabriel Zada2.   

Abstract

Central neurocytoma (CN) is an important consideration in the differential diagnosis of any intraventricular lesion. Initial evaluation should include noncontrast CT, MRI with and without gadolinium contrast, and magnetic resonance (MR) spectroscopy, if available. CN classically appear as a partially calcified mass on CT, arising from the septum pellucidum or foramen of Monro, with a soap-bubble multicystic appearance on MR T2-imaging and heterogeneous enhancement on MR T1 postcontrast imaging. MR perfusion/permeability and dynamic contrast imaging are experimental and promising tools in the diagnosis of CN.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; Central neurocytomas; Computed tomography; Intraventricular tumor; Magnetic resonance imaging; Magnetic resonance spectroscopy; Neuroradiology

Mesh:

Year:  2015        PMID: 25432179     DOI: 10.1016/j.nec.2014.09.012

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

1.  Diagnostic value of six MRI features for central neurocytoma.

Authors:  Xiaodan Li; Liuji Guo; Sen Sheng; Yikai Xu; Lichao Ma; Xiang Xiao; Zhiguang Si; Yanping Chen; Yuankui Wu
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

2.  Neurocytoma mimicking macroadenoma.

Authors:  Breno Nery; Fred Bernardes Filho; Rodrigo Antônio Fernandes Costa; Leandro César Tângari Pereira; Eduardo Quaggio; Rodolfo Mendes Queiroz; Lucas Giansante Abud; Daniela Pretti da Cunha Tirapelli
Journal:  Surg Neurol Int       Date:  2019-01-21

Review 3.  Systematic Analysis of Clinical Outcomes Following Stereotactic Radiosurgery for Central Neurocytoma.

Authors:  Timothy T Bui; Carlito Lagman; Lawrance K Chung; Stephen Tenn; Percy Lee; Robert K Chin; Tania Kaprealian; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.